Q871M9
Gene name |
stk-1 (bur1, B20D17.070, NCU01435) |
Protein name |
Serine/threonine-protein kinase bur1 |
Names |
Serine-threonine kinase 1 |
Species |
Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) |
KEGG Pathway |
ncr:NCU01435 |
EC number |
2.7.11.22: Protein-serine/threonine kinases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
188-222 (Activation loop from InterPro)
Target domain |
40-341 (Protein kinase domain) |
Relief mechanism |
|
Assay |
|
Autoinhibited structure
Activated structure
1 structures for Q871M9
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q871M9-F1 | Predicted | AlphaFoldDB |
No variants for Q871M9
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q871M9 | |||||
No associated diseases with Q871M9
Functions
| Description | ||
|---|---|---|
| EC Number | 2.7.11.22 | Protein-serine/threonine kinases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cyclin-dependent protein kinase holoenzyme complex | Cyclin-dependent protein kinases (CDKs) are enzyme complexes that contain a kinase catalytic subunit associated with a regulatory cyclin partner. |
| cyclin/CDK positive transcription elongation factor complex | A transcription elongation factor complex that facilitates the transition from abortive to productive elongation by phosphorylating the CTD domain of the large subunit of DNA-directed RNA polymerase II, holoenzyme. Contains a cyclin and a cyclin-dependent protein kinase catalytic subunit. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| cyclin binding | Binding to cyclins, proteins whose levels in a cell varies markedly during the cell cycle, rising steadily until mitosis, then falling abruptly to zero. As cyclins reach a threshold level, they are thought to drive cells into G2 phase and thus to mitosis. |
| cyclin-dependent protein serine/threonine kinase activity | Cyclin-dependent catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
| protein serine kinase activity | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. |
| RNA polymerase II CTD heptapeptide repeat kinase activity | Catalysis of the reaction: ATP + RNA polymerase II large subunit CTD heptapeptide repeat (YSPTSPS) = ADP + H+ + phosphorylated RNA polymerase II. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| phosphorylation of RNA polymerase II C-terminal domain | The process of introducing a phosphate group on to an amino acid residue in the C-terminal domain of RNA polymerase II. Typically, this occurs during the transcription cycle and results in production of an RNA polymerase II enzyme where the carboxy-terminal domain (CTD) of the largest subunit is extensively phosphorylated, often referred to as hyperphosphorylated or the II(0) form. Specific types of phosphorylation within the CTD are usually associated with specific regions of genes, though there are exceptions. The phosphorylation state regulates the association of specific complexes such as the capping enzyme or 3'-RNA processing machinery to the elongating RNA polymerase complex. |
| positive regulation of transcription elongation by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II. |
| protein phosphorylation | The process of introducing a phosphate group on to a protein. |
| transcription elongation by RNA polymerase II promoter | The extension of an RNA molecule after transcription initiation and promoter clearance at an RNA polymerase II promoter by the addition of ribonucleotides catalyzed by RNA polymerase II. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSIDEAKEGG | GGPAMSPRAF | ALAHQRDRGS | FVGCSRIADY | EVLGKLGEGT | FGEVHRARSR |
| 70 | 80 | 90 | 100 | 110 | 120 |
| KTGALVALKK | IIMHNERDGF | PITALREIKL | LKLLSHKNVL | RLEEMAIEHP | PRTDKRTRPI |
| 130 | 140 | 150 | 160 | 170 | 180 |
| VYMVTPYMDH | DLSGLLDNPS | VRFTEPQVKC | YLLQLLEGLK | YLHANHILHR | DMKAANLLIN |
| 190 | 200 | 210 | 220 | 230 | 240 |
| NKGVLQIADF | GLARHYEGDI | PQPGKGSGEG | KRDYTSLVVT | RWYRPPELLM | HLKRYTTAID |
| 250 | 260 | 270 | 280 | 290 | 300 |
| MWGVGCVFAE | MLEGKPVLQG | ESDLHQLELV | WDLCGTPSEE | TMPGWRTLPG | GQAFSSKPRP |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GNLARRFEKH | GPVVISLLKE | LFKLDWRSRI | NAIDALNHPY | FRTAPLPALP | GDLPTFEESH |
| 370 | 380 | 390 | 400 | 410 | 420 |
| EFDRRKFQDR | KAALPPAPKG | GTVGRGAVVN | SQGPDTGFSG | RDGYGGGGRN | GANGGRYPPY |
| 430 | 440 | 450 | 460 | 470 | 480 |
| HRGPPPGDER | VPSWHSARGL | PPRPPMPADY | HGSGPMDHTD | GYRDRPPRRG | PGGPPGGGGG |
| 490 | 500 | 510 | 520 | 530 | 540 |
| PSNVDTYIPS | YDRDGPAPRR | EDWRRRDDWD | DRRGGVDRDR | RRPEYDVRSR | DSRTRSRTRS |
| 550 | |||||
| RSPVRDRDRG | RDRDAYARR |